Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/19/24 16:31 | 11/15/24 | XFOR | Health | BioPrd | Biological Products, (No Diag | Ragan Paula | MA | DO | P,CEO | 3 | S | -162 | 0.5344 | 0 | -303 | 1,058 | D | |||||||||||||||
10/8/24 16:44 | 10/7/24 | XFOR | Health | BioPrd | Biological Products, (No Diag | Mostafa Adam S. | MA | O | CFO | 1 | S | -127 | 0.5502 | 0 | -231 | -100 | 0 | D | ||||||||||||||
10/8/24 16:44 | 10/7/24 | XFOR | Health | BioPrd | Biological Products, (No Diag | Baldry Mark | MA | O | Chief Co | 1 | S | -7 | 0.5847 | 0 | -11 | 49 | D | |||||||||||||||
10/8/24 16:44 | 10/7/24 | XFOR | Health | BioPrd | Biological Products, (No Diag | Dibiase Mary | MA | O | COO | 2 | S | -40 | 0.5696 | 0 | -70 | 452 | D | |||||||||||||||
10/8/24 16:44 | 10/7/24 | XFOR | Health | BioPrd | Biological Products, (No Diag | Taveras Arthur | MA | O | Chief Sc | 1 | S | -43 | 0.5630 | 0 | -77 | 388 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |